Reuters logo
BRIEF-Critical Outcome Activates Second Clinical Trial Site for Its COTI-2 Gynecological Cancer Study
2016年6月6日 / 下午12点52分 / 1 年前

BRIEF-Critical Outcome Activates Second Clinical Trial Site for Its COTI-2 Gynecological Cancer Study

June 6 (Reuters) - Critical Outcome Technologies Inc :

* Critical Outcome Activates Second Clinical Trial Site for Its COTI-2 Gynecological Cancer Study Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below